X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $54.63 | -14,375 | 28,507 | -34% | -$785,306 | |||||
| D | 2024-07-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.87 | -14,375 | 28,507 | -34% | -$645,006 | |||||
| D | 2024-06-24 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $45.73 | -9,500 | 27,786 | -25% | -$434,435 | |||||
| D | 2024-04-15 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.47 | -14,375 | 27,786 | -34% | -$639,256 | |||||
| D | 2024-03-20 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.06 | -15,089 | 27,786 | -35% | -$664,763 | |||||
| D | 2024-01-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $35.00 | -14,375 | 5,911 | -71% | -$503,125 | |||||
| D | 2023-12-21 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $34.57 | -9,583 | 5,911 | -62% | -$331,284 | |||||
2023-04-05 | CRNX | Pizzuti Dana | Chief Development Officer | S - Sale | $16.15 | -8,212 | 4,500 | -65% | -$132,624 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |